Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hohmann, Jan David"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
A Recombinant Fusion Construct between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices.
Autorzy:
Abraham MK; Clinical Research Laboratory, Department of Thoracic, Cardiac and Vascular Surgery, University Hospital Tübingen, 72076 Tübingen, Germany.; Atherothrombosis and Vascular Biology, Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.; Molecular Imaging and Theranostics Laboratory, Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.
Jost E; Clinical Research Laboratory, Department of Thoracic, Cardiac and Vascular Surgery, University Hospital Tübingen, 72076 Tübingen, Germany.; Atherothrombosis and Vascular Biology, Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.; Molecular Imaging and Theranostics Laboratory, Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.
Hohmann JD; Atherothrombosis and Vascular Biology, Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.
Searle AK; Atherothrombosis and Vascular Biology, Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.; Molecular Imaging and Theranostics Laboratory, Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.; Department of Medicine, Monash University, Melbourne, VIC 3800, Australia.
Bongcaron V; Atherothrombosis and Vascular Biology, Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.; Molecular Imaging and Theranostics Laboratory, Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.
Song Y; Molecular Imaging and Theranostics Laboratory, Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.; Department of Cardiometabolic Health, University of Melbourne, Melbourne, VIC 3010, Australia.
Wendel HP; Clinical Research Laboratory, Department of Thoracic, Cardiac and Vascular Surgery, University Hospital Tübingen, 72076 Tübingen, Germany.
Peter K; Atherothrombosis and Vascular Biology, Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.; Department of Medicine, Monash University, Melbourne, VIC 3800, Australia.; Department of Cardiometabolic Health, University of Melbourne, Melbourne, VIC 3010, Australia.; La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.
Krajewski S; Clinical Research Laboratory, Department of Thoracic, Cardiac and Vascular Surgery, University Hospital Tübingen, 72076 Tübingen, Germany.
Wang X; Molecular Imaging and Theranostics Laboratory, Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.; Department of Medicine, Monash University, Melbourne, VIC 3800, Australia.; Department of Cardiometabolic Health, University of Melbourne, Melbourne, VIC 3010, Australia.; La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2021 Sep 18; Vol. 13 (9). Date of Electronic Publication: 2021 Sep 18.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.
Autorzy:
Abraham MK; Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany.
Nolte A; Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany.
Reus R; Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany.
Behring A; Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany.
Zengerle D; Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany.
Avci-Adali M; Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany.
Hohmann JD; Atherothrombosis and Vascular Biology, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia.
Peter K; Atherothrombosis and Vascular Biology, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia.
Schlensak C; Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany.
Wendel HP; Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany.
Krajewski S; Department of Thoracic, Cardiac and Vascular Surgery, Clinical Research Laboratory, University Hospital Tuebingen, Teubingen, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Sep 18; Vol. 10 (9), pp. e0138375. Date of Electronic Publication: 2015 Sep 18 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angioplasty/*methods
Antigens, CD/*genetics
Apyrase/*genetics
Atherosclerosis/*surgery
RNA, Messenger/*therapeutic use
Stents/*adverse effects
Angioplasty/adverse effects ; Animals ; Antigens, CD/metabolism ; Apyrase/metabolism ; Cell Line ; Endothelial Cells/metabolism ; HEK293 Cells ; Humans ; Swine
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies